On this page: From 6 months to 35 months | From the age of 3 years | Further information | Reporting of adverse events following influenza vaccine
From 6 months to 35 months
For the 2018 influenza season, the following quadrivalent influenza vaccine will be registered and available for use in children from 6 months to 35 months inclusive (less than 3 years):
- Sanofi-Aventis - FluQuadri Junior
From the age of 3 years
For the 2018 influenza season, in addition to the vaccine for 6 months to 35 months inclusive mentioned above, the following quadrivalent influenza vaccines will be registered and available for use in children from the age of 3 years:
- GlaxoSmithKline - Fluarix Tetra
- Sanofi-Aventis - FluQuadri
Further information
For further information see the TGA's statement regarding 2018 seasonal influenza vaccines.
For further information on individual vaccines, please refer to the relevant Product Information document or Consumer Medicine Information document.
In conjunction with the Office of Health Protection and state and territory health authorities, the TGA will be closely monitoring adverse event reports during the 2018 influenza vaccination program.
The 2018 seasonal influenza vaccines provided free through the National Immunisation Program will be available from April 2018.
Reporting of adverse events following influenza vaccine
Health professionals and consumers are encouraged to report all adverse events associated with influenza vaccination in patients of any age to the TGA or through the current arrangements in their state or territory.
All reports contribute to the TGA's ongoing monitoring of the safety of influenza vaccines.
The TGA cannot give advice about an individual's medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a vaccine or medicine.